Type 2 Diabetes News and Research RSS Feed - Type 2 Diabetes News and Research

Type 2 diabetes, formerly called adult-onset or noninsulindependent diabetes, is the most common form of diabetes. People can develop type 2 diabetes at any age, even during childhood. This form of diabetes usually begins with insulin resistance, a condition in which fat, muscle, and liver cells do not use insulin properly. At first, the pancreas keeps up with the added demand by producing more insulin. In time, however, it loses the ability to secrete enough insulin in response to meals. People who are overweight and inactive are more likely to develop type 2 diabetes. Treatment includes taking diabetes medicines, making wise food choices, exercising regularly, controlling blood pressure and cholesterol, and taking aspirin daily—for some.
Dairy products contribute to overall metabolic health

Dairy products contribute to overall metabolic health

Dairy is considered part of a healthy diet and dietary guidelines recommend the daily consumption of 2-4 portions of milk-based products such as milk, yogurt, cheese, cream and butter. [More]
ADA Maryland Chapter, WellDoc collaborate to empower patients with type 2 diabetes

ADA Maryland Chapter, WellDoc collaborate to empower patients with type 2 diabetes

The American Diabetes Association (ADA) Maryland Chapter and WellDoc®, a health care behavioral science and technology company, have announced the launch of a collaboration to empower people in Maryland with type 2 diabetes to take control of their diabetes by improving their day-to-day self-management. [More]
Brain stimulation increases cravings for high-calorie foods, shows study

Brain stimulation increases cravings for high-calorie foods, shows study

Magnetic stimulation of a brain area involved in "executive function" affects cravings for and consumption of calorie-dense snack foods, reports a study in the September issue of Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. [More]
Gut hormone-drug combination therapy more effective at improving type 2 diabetes

Gut hormone-drug combination therapy more effective at improving type 2 diabetes

Combined treatment with a drug that mimics the action of a gut hormone and basal insulin is more effective at improving blood sugar control than other anti-diabetic treatments, with similar rates of hypoglycaemia (dangerously low blood sugar levels) and greater weight loss, a systematic review and meta-analysis published in The Lancet shows. [More]
FDA approves Contrave extended-release tablets for chronic weight management

FDA approves Contrave extended-release tablets for chronic weight management

Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition. [More]
New research shows statins could reduce common diabetes complications

New research shows statins could reduce common diabetes complications

The development of common diabetes complications that can lead to blindness and amputations could be reduced by taking statins, indicates new research published in The Lancet Diabetes & Endocrinology. [More]
Clinical trial of stem cell-derived therapy for patients with Type 1 diabetes

Clinical trial of stem cell-derived therapy for patients with Type 1 diabetes

Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes. [More]
Lilly and Boehringer Ingelheim's insulin glargine product gets marketing approval from EC

Lilly and Boehringer Ingelheim's insulin glargine product gets marketing approval from EC

The European Commission granted marketing authorisation for Eli Lilly and Company and Boehringer Ingelheim's insulin glargine product, indicated to treat diabetes in adults, adolescents and children aged 2 years and above. [More]
Positive outlook and support from people help diabetes patients cope with psychosocial challenges

Positive outlook and support from people help diabetes patients cope with psychosocial challenges

A positive outlook and support from people around them help patients with diabetes cope with psychosocial challenges of the disease, according to an international study that included researchers from Penn State College of Medicine. [More]
Study ties eating in response to food cues to habit-forming region in obese adults

Study ties eating in response to food cues to habit-forming region in obese adults

People who are obese may be more susceptible to environmental food cues than their lean counterparts due to differences in brain chemistry that make eating more habitual and less rewarding, according to a National Institutes of Health study published in Molecular Psychiatry. [More]
Regular consumption of mango by obese adults may lower blood sugar levels

Regular consumption of mango by obese adults may lower blood sugar levels

Research published in the journal Nutrition and Metabolic Insights found that regular consumption of mango by obese adults may lower blood sugar levels and does not negatively impact body weight. [More]
AMPK gene can slow aging process when activated remotely in key organ systems

AMPK gene can slow aging process when activated remotely in key organ systems

UCLA biologists have identified a gene that can slow the aging process throughout the entire body when activated remotely in key organ systems. [More]
Inflammatory marker signals diabetic nephropathy development

Inflammatory marker signals diabetic nephropathy development

Measuring serum levels of high-sensitivity C-reactive protein could help to predict which patients with Type 2 diabetes will develop renal disease, research suggests. [More]
Intensive glycaemic control shows ischaemic heart disease benefit

Intensive glycaemic control shows ischaemic heart disease benefit

Intensive glucose lowering may significantly reduce the risk of ischaemic heart disease in at-risk middle-aged people with Type 2 diabetes, a post-hoc analysis of the ACCORD trial suggests. [More]
Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

Fractyl Laboratories Inc. today announced positive clinical data for the first procedural therapy to directly treat the underlying digestive causes of insulin resistance in patients with uncontrolled type 2 diabetes. [More]
Professor receives grant from NIH to test effects of high-intensity functional training

Professor receives grant from NIH to test effects of high-intensity functional training

Katie Heinrich, assistant professor of kinesiology at Kansas State University, has been awarded an investigator-initiated grant from the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases for more than $2.52 million. [More]
Accreditation of bariatric surgery centers contributes to improved safety for patients

Accreditation of bariatric surgery centers contributes to improved safety for patients

Patients who underwent weight loss operations in recent years, when most bariatric surgical centers were accredited, had fewer postoperative complications and were 2.3 times less likely to die in the hospital than patients who had bariatric procedures performed before a national movement toward facility accreditation was taking place, according to new study findings. [More]
Type 2 diabetes adds to hospital mortality risk in bipolar patients

Type 2 diabetes adds to hospital mortality risk in bipolar patients

Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows. [More]
Researchers discover protein that may open door to new method of treating type 2 diabetes

Researchers discover protein that may open door to new method of treating type 2 diabetes

The STK25 protein contributes to cell growth. Researchers at Sahlgrenska Academy have discovered that the protein also affects metabolism, demonstrating that elevated levels accelerate the progress of diabetes in mice. [More]
Coffee increases risk of prediabetes in young adults with hypertension

Coffee increases risk of prediabetes in young adults with hypertension

Coffee increases the risk of prediabetes in young adults with hypertension who are slow caffeine metabolisers, according to results from the HARVEST study presented at ESC Congress today by Dr Lucio Mos from Italy. People who drank more than three cups of coffee per day doubled their risk of prediabetes. [More]